Search Results - "Lušin, Tina Trdan"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Matrixing Designs for Shelf-Life Determination of Parenteral Drug Product: A Comparative Analysis of Full and Reduced Stability Testing Design by Pavčnik, Lara, Locatelli, Igor, Trdan Lušin, Tina, Roškar, Robert

    Published in Pharmaceutics (01-09-2024)
    “…This article highlights the applicability of matrixing designs in stability studies for parenteral medications. The traditional approach involves extensive…”
    Get full text
    Journal Article
  2. 2

    Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination by Peterka, Tanja Rozman, Lušin, Tina Trdan, Bergles, Jure, Ham, Zoran, Grahek, Rok, Urleb, Uroš

    Published in Acta Pharmaceutica (01-09-2019)
    “…An ultra-high performance liquid chromatography method for simultaneous determination of tacrolimus impurities in pharmaceutical dosage forms has been…”
    Get full text
    Journal Article Paper
  3. 3

    Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles by Kovač, Lidija, Časar, Zdenko, Trdan Lušin, Tina, Roškar, Robert

    Published in ACS omega (15-03-2022)
    “…Cabotegravir is one of the newly approved human immunodeficiency virus (HIV) integrase enzyme inhibitors used for the prevention and treatment of HIV…”
    Get full text
    Journal Article
  4. 4

    Evaluation of bisphenol A glucuronidation according to UGT1A128 polymorphism by a new LC–MS/MS assay by Trdan Lušin, Tina, Roškar, Robert, Mrhar, Aleš

    Published in Toxicology (Amsterdam) (06-02-2012)
    “…The endocrine disruptor bisphenol A (BPA) is a frequently used chemical in the manufacture of consumer products. In humans, BPA is extensively metabolized to…”
    Get full text
    Journal Article
  5. 5

    Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates by Lengauer, Hannes, Makuc, Damjan, Šterk, Damjan, Perdih, Franc, Pichler, Arthur, Trdan Lušin, Tina, Plavec, Janez, Časar, Zdenko

    Published in Pharmaceutics (10-04-2020)
    “…Tenofovir alafenamide fumarate (TAF) is the newest prodrug of tenofovir that constitutes several drug products used for the treatment of HIV/AIDS. Although the…”
    Get full text
    Journal Article
  6. 6

    Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene by Trdan Lušin, Tina, Stieger, Bruno, Marc, Janja, Mrhar, Aleš, Trontelj, Jurij, Zavratnik, Andrej, Ostanek, Barbara

    Published in Journal of translational medicine (25-04-2012)
    “…Raloxifene, a selective estrogen receptor modulator, exhibits quite large and unexplained interindividual variability in pharmacokinetics and pharmacodynamics…”
    Get full text
    Journal Article
  7. 7

    Fast and Simple LC-MS/MS Method for Rifampicin Quantification in Human Plasma by Trontelj, Jurij, Kristl, Albin, Grabnar, Iztok, Faganeli, Nataša, Trdan Lušin, Tina, Klančar Andrejc, Anita, Roškar, Robert, Temova Rakuša, Žane, Mrhar, Aleš

    “…A simple, fast, and cost-effective LC-MS/MS method for quantification of rifampicin in human plasma was developed and fully validated. The plasma samples…”
    Get full text
    Journal Article
  8. 8

    Understanding of cabotegravir degradation through isolation and characterization of key degradation products and kinetic studies by Kovač, Lidija, Črnugelj, Martin, Roškar, Robert, Trdan Lušin, Tina, Časar, Zdenko

    “…[Display omitted] •Cabotegravir stability characteristics were established under stress conditions.•Key degradation products of cabotegravir formed under…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Raloxifene Glucuronidation in Human Intestine, Kidney, and Liver Microsomes and in Human Liver Microsomes Genotyped for the UGT1A128 Polymorphism by TINA TRDAN LUSIN, TRONTELJ, Jurij, MRHAR, Aleš

    Published in Drug metabolism and disposition (01-12-2011)
    “…Raloxifene, a selective estrogen receptor modulator, exhibits quite large interindividual variability in pharmacokinetics and pharmacodynamics. In women,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Efflux and uptake transporters involved in the disposition of bazedoxifene by Lušin, Tina Trdan, Mrhar, Aleš, Stieger, Bruno, Kristl, Albin, Berginc, Katja, Trontelj, Jurij

    “…Bazedoxifene, a novel selective estrogen receptor modulator, has complex pharmacokinetics with rapid absorption, high metabolic clearance, low oral…”
    Get full text
    Journal Article
  13. 13

    In vitro bioactivation of bazedoxifene and 2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol in human liver microsomes by Lušin, Tina Trdan, Tomašić, Tihomir, Trontelj, Jurij, Mrhar, Aleš, Peterlin-Mašič, Lucija

    Published in Chemico-biological interactions (15-04-2012)
    “…[Display omitted] . ► We examined in vitro bioactivation of bazedoxifene and N-dealkylated fragment of bazedoxifene in HLM and with P450 isozymes. ►…”
    Get full text
    Journal Article
  14. 14

    Inverse correlation of carotid intima-media thickness with raloxifene serum levels in osteoporosis by Lušin, Tina Trdan, Mrhar, Aleš, Marc, Janja, Trontelj, Jurij, Zavratnik, Andrej, Žegura, Branka, Pfeifer, Marija, Ostanek, Barbara

    Published in Wiener Klinische Wochenschrift (01-07-2014)
    “…Summary Background Raloxifene is a selective oestrogen receptor modulator with effects on bone and breast cancer and cardiovascular disease risk. The aim of…”
    Get full text
    Journal Article
  15. 15

    Evaluation of bisphenol A glucuronidation according to UGT1A1 28 polymorphism by a new LC–MS/MS assay by Trdan Lušin, Tina, Roškar, Robert, Mrhar, Aleš

    Published in Toxicology (Amsterdam) (2011)
    “…Abstract The endocrine disruptor bisphenol A (BPA) is a frequently used chemical in the manufacture of consumer products. In humans, BPA is extensively…”
    Get full text
    Journal Article